Progressive supranuclear palsy
2014; Mark Allen Group; Volume: 10; Issue: 2 Linguagem: Inglês
10.12968/bjnn.2014.10.2.64
ISSN2052-2800
Autores Tópico(s)Neurological disorders and treatments
ResumoBritish Journal of Neuroscience NursingVol. 10, No. 2 Clinical BriefingProgressive supranuclear palsyBoyd CP GhoshBoyd CP GhoshSearch for more papers by this authorBoyd CP GhoshPublished Online:2 May 2014https://doi.org/10.12968/bjnn.2014.10.2.64AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Albert ML, Feldman RG, Willis AL (1974) The ‘subcortical dementia’ of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37(2): 121–30 Crossref, Google ScholarBak TH, Hodges J (1998) The neuropsychology of progressive supranuclear palsy. Neurocase 4: 89–94 Crossref, Google ScholarGhosh BC, Calder AJ, Peers PVet al. (2012) Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 135(Pt 7): 2089–102. doi: https://doi.org/10.1093/brain/aws128 Crossref, Google ScholarGhosh BC1, Carpenter RH, Rowe JB (2013) A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy. PLoS ONE 8(9): e74486. doi: https://doi.org/10.1371/journal.pone.0074486 Crossref, Google ScholarGowers WR (1888) A Manual of Diseases of the Nervous System. P Blakiston, Son & Co Google ScholarHoenicka J, Pérez M, Pérez-Tur Jet al. (1999) The tau gene A0 allele and progressive supranuclear palsy. Neurology 53(6): 1219–25 Crossref, Google ScholarKertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128(9): 1996–2005 Crossref, Google ScholarLing H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain 135(4): 1141–53. doi: https://doi.org/10.1093/brain/aws038 Crossref, Google ScholarLitvan I, Mangone CA, McKee Aet al. (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60(6): 615–20 Crossref, Google ScholarLitvan I, Bhatia KP, Burn DJet al. (2003) Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18(5): 467–86 Crossref, Google ScholarMassey LA, Micallef C, Paviour DCet al. (2012) Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 27(14): 1754–62. doi: https://doi.org/10.1002/mds.24968 Crossref, Google ScholarPerneczky R, Ghosh BC, Hughes L, Carpenter RH, Barker RA, Rowe JB (2011) Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity. Neurobiol Dis 43(1): 79–85. doi: https://doi.org/10.1016/j.nbd.2011.01.032 Crossref, Google ScholarPSP Association (2012) Pathway of Care for PSP: A guide for Health and Social Care Professionals. www.pspassociation.org.uk/wp-content/uploads/2012/09/Publications-list.pdf?773bdd (accessed 26 March 2014) Google ScholarRichardson JC, Steele J, Olszewski J (1963) Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of “heterogenous system degeneration.” Trans Am Neurol Assoc 88: 25–9 Google ScholarRittman T, Ghosh BC, McColgan Pet al. (2013) The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84(5): 544–51. doi: https://doi.org/10.1136/jnnp-2012-303618 Crossref, Google ScholarSchrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354(9192): 1771–5 Crossref, Google ScholarSelikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinicopathological study of subtypes in Parkinson's disease. Brain 132(Pt 11): 2947–57. doi: https://doi.org/10.1093/brain/awp234 Crossref, Google ScholarWilliams DR, de Silva R, Paviour DCet al. (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128(6): 1247–58 Crossref, Google ScholarWilliams DR, Holton JL, Strand K, Revesz T, Lees AJ (2007) Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22(15): 2235–41 Crossref, Google ScholarWilliams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8(3): 270–9 doi: https://doi.org/10.1016/S1474-4422(09)70042-0 Crossref, Google Scholar FiguresReferencesRelatedDetailsCited byEffectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsyJBI Database of Systematic Reviews and Implementation Reports, Vol. 14, No. 6Multiple system atrophy24 June 2014 | British Journal of Neuroscience Nursing, Vol. 10, No. 3 2 April 2014Volume 10Issue 2ISSN (print): 1747-0307ISSN (online): 2052-2800 Metrics History Published online 2 May 2014 Published in print 2 April 2014 Information© MA Healthcare LimitedPDF download
Referência(s)